AZN - AstraZeneca's Farxiga approved for type 2 diabetes for children as young as 10
2024-06-12 15:30:16 ET
More on AstraZeneca
- AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, I'm Pausing For Breath
- AstraZeneca: A Triple Shot Of Income, Growth, And Value
- AstraZeneca: Strong In A Weak Market
- AstraZeneca’s Tagrisso gets FDA priority review in lung cancer subtype
- AstraZeneca dominates, Merck’s Keytruda beaten as ASCO 2024 concludes